Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HBV core protein inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B | Preclinical | US | 28 Jan 2023 | |
Hepatitis B | Preclinical | BE | 28 Jan 2023 | |
Hepatitis B | Preclinical | FR | 28 Jan 2023 |